AGO Study Group

NCT05009082

Phase 3, Recruiting, 2022, 970 people, 17 Aug 2021, clinicaltrials.gov

NCT04111978

Collaborator, Phase 3, Recruiting, 2020, 540 people, 2 Oct 2019, clinicaltrials.gov

NCT03598270

Collaborator, Phase 3, Completed, 2018, 417 people, 26 Jul 2018, clinicaltrials.gov

NCT03556839

Collaborator, Phase 3, Completed, 2018, 410 people, 14 Jun 2018, clinicaltrials.gov

NCT01864746

Collaborator, Phase 3, Completed, 2013, 1,250 people, 30 May 2013, clinicaltrials.gov

NCT01462890

Phase 3, Completed, 2011, 927 people, 1 Nov 2011, clinicaltrials.gov

NCT00815945

Phase 2, Completed, 2008, 41 people, 31 Dec 2008, clinicaltrials.gov

NCT00795899

Collaborator, Phase 2, Completed, 2002, 230 people, 21 Nov 2008, clinicaltrials.gov

NCT00567554

Collaborator, Phase 3, Completed, 2007, 2,600 people, 5 Dec 2007, clinicaltrials.gov

NCT00281515

Phase 2, Completed, 2006, 105 people, 25 Jan 2006, clinicaltrials.gov

NCT00189553

Collaborator, Phase 3, Completed, 2005, 976 people, 19 Sept 2005, clinicaltrials.gov

NCT00189371

Phase 3, Terminated, 2004, 300 people, 19 Sept 2005, clinicaltrials.gov

NCT00189358

Phase 2, Completed, 19 Sept 2005, clinicaltrials.gov

NCT00006454

Phase 3, Completed, 1999, 3 Feb 2004, clinicaltrials.gov

NCT00006453

Phase 3, Completed, 1999, 28 Jul 2003, clinicaltrials.gov

NCT00031954

Phase 2, Completed, 2001, 105 people, 1 Jul 2003, clinicaltrials.gov

NCT00052468

Phase 3, Completed, 2002, 1,742 people, 27 Jan 2003, clinicaltrials.gov

NCT00032162

Phase 1/2, Completed, 2001, 63 people, 27 Jan 2003, clinicaltrials.gov

NCT00046969

Phase 4, Completed, 2002, 450 people, 27 Jan 2003, clinicaltrials.gov